Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis
JAMA Neurol 2023 Nov 27;[EPub Ahead of Print], J Kim, AS Kesselheim, R Bove, J Avorn, BN RomeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.